IONS vs LNKB · rev $514.0M vs P/E 7.9, rev $167.6M
Ionis Pharmaceuticals Inc (IONS) versus LINKBANCORP Inc (LNKB) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
LINKBANCORP Inc (LNKB) is a banks - regional company listed on US.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
Latest reported LNKB revenue for 2024-12-31 was $167.6M. Net income was $26.2M. Revenue was up 152.8% from 2023-12-31 to 2024-12-31. LNKB currently screens at market cap $286.7M and trailing P/E 7.9.
IONS currently screens at market cap $12.28B. LNKB currently screens at market cap $286.7M and trailing P/E 7.9.
Not investment advice. Open the IONS and LNKB stock pages for the full models.
Not investment advice.